<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04405479</url>
  </required_header>
  <id_info>
    <org_study_id>EK-VP/23/0/2014</org_study_id>
    <nct_id>NCT04405479</nct_id>
  </id_info>
  <brief_title>Resting Postural Tremor in Multiple Sclerosis</brief_title>
  <official_title>Spectral Analyses of Resting Postural Tremor Measured by Accelerometer and Gyroscope as a Predictive Tool of Multiple Sclerosis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Charles University, Czech Republic</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Charles University, Czech Republic</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Early diagnosis is a key factor for effective treatment of multiple sclerosis. Accelerometer
      and gyroscope measurement of tremor could screen potential motor control dysfunction and
      predict a risk for development of multiple sclerosis.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The aim of this study is to test whether specially developed accelerometer and gyroscope can
      differentiate pattern of resting postural tremor in healthy and people with multiple
      sclerosis.

      Spectral analysis and the correlation of the average signal spectra will be computed.
      Moreover, categorization based on the tremor component according to the maximum likelihood
      estimation will be done.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">August 1, 2020</start_date>
  <completion_date type="Anticipated">September 30, 2020</completion_date>
  <primary_completion_date type="Anticipated">August 28, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Tremor</measure>
    <time_frame>baseline</time_frame>
    <description>accelerometer (1 m·s-2)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Hand grip strength</measure>
    <time_frame>baseline</time_frame>
    <description>Hand dynamometer JAMA</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hand and arm function</measure>
    <time_frame>baseline</time_frame>
    <description>Nine Hole Peg Test</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Psychomotor processing speed</measure>
    <time_frame>baseline</time_frame>
    <description>Coin Rotation Task</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Multiple Sclerosis</condition>
  <arm_group>
    <arm_group_label>Patients with multiple sclerosis</arm_group_label>
    <description>MS patients will be chosen by an independent neurologist.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Healthy volunteers</arm_group_label>
    <description>Healthy controls will be paired by age and sex with MS patients.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Examination of tremor and upper hand functions</intervention_name>
    <description>Participants will be only examined. They will not undergo any intervention.</description>
    <arm_group_label>Healthy volunteers</arm_group_label>
    <arm_group_label>Patients with multiple sclerosis</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        People with MS and healthy volunteers
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Group 1:

          -  Definite diagnosis of MS

          -  prevailed motor deficit of upper extremities, but without visible tremor

          -  stable clinical status in the preceding 3 months

          -  Expanded Disability Status Scale score (EDSS) ≥ 2 ≤ 7.5, and

          -  no corticosteroid therapy in the preceding month

        Group 2:

          -  Healthy volunteers in the age of 20-70 years will be employed

          -  There will be defined as persons without any neurological disease diagnose at the time
             of the measurement.

        Exclusion Criteria (both groups):

        Patients with factors disturbing mobility (e.g. stroke, pregnancy, fractures) were excluded
        from the study.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Kamila Řasová, Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Third Faculty of Mecicine, Charles Univerzity</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Kamila Řasová, Ph.D.</last_name>
    <phone>+420604511416</phone>
    <email>kamila.rasova@gmail.com</email>
  </overall_contact>
  <verification_date>June 2020</verification_date>
  <study_first_submitted>May 20, 2020</study_first_submitted>
  <study_first_submitted_qc>May 27, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">May 28, 2020</study_first_posted>
  <last_update_submitted>June 18, 2020</last_update_submitted>
  <last_update_submitted_qc>June 18, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">June 19, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Charles University, Czech Republic</investigator_affiliation>
    <investigator_full_name>Kamila Řasová</investigator_full_name>
    <investigator_title>associate professor PhDr. Kamila Řasová, Ph.D.</investigator_title>
  </responsible_party>
  <keyword>Tremor</keyword>
  <keyword>Accelerometer</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Multiple Sclerosis</mesh_term>
    <mesh_term>Tremor</mesh_term>
    <mesh_term>Sclerosis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

